The trademark application ENPOLYAB was filed by BIOTEST AG, a corporation established under the laws of the Federal Republic of Germany (the "Applicant"). The application was published for oppositions on April 29, 2021, and it was registered by office on August 6, 2021 without any oppositions.
It was designated 'Basic Application' for International Application 1626400 at the World Intellectual Property Organization (WIPO).
The application was filed in English (German was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceutical products, medical products, namely, blood products, medical preparations
In particular: Blood products, serum preparations, in particular serum proteins and solutions containing the same
Proteins and protein preparations made from human blood, blood plasma or blood serum
In particular immunoglobulin preparations, immunoglobulins and hyperimmunoglobulins
Pharmaceutical products for immunology, neurology, intensive medicine, transplantation medicine, oncology
Pharmaceutical products for preventing and treating viral diseases, diseases of the immune system, autoimmune diseases and oncological diseases
Immunosuppressant, immunomodulatory, anti-inflammatory, antiallergic, hyposensitizing and detoxifying or toxine-neutralizing medicines.